Lab Reagents

Human IgG antibody Laboratories manufactures the assay designs ann arbor mi reagents distributed by Genprice. The Assay Designs Ann Arbor Mi reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Arbor Assays. Other Assay products are available in stock. Specificity: Assay Category: Designs Group: Ann Arbor

Ann Arbor information

Assay Buffer Concentrate, 55ML
X088-55ML	Arbor Assays	55ML	EUR 171.6

Assay Buffer Concentrate, 25ML
X106-25ML	Arbor Assays	25ML	EUR 130.8

Assay Buffer Concentrate, 28ML
X111-28ML	Arbor Assays	28ML	EUR 147.6

Assay Buffer Concentrate, 28ML
X112-28ML	Arbor Assays	28ML	EUR 147.6

Assay Buffer Concentrate, 25ML
X121-25ML	Arbor Assays	25ML	EUR 130.8

Assay Buffer Concentrate, 28ML
X122-28ML	Arbor Assays	28ML	EUR 147.6

Assay Buffer Concentrate, 28ML
X132-28ML	Arbor Assays	28ML	EUR 147.6

MI-2
A3602-10	ApexBio	10 mg	EUR 338.4
Description: MI-2 is a Menin-MLL inhibitor with IC50 value of 0.45 ?M [1]. Mixed-lineage leukemia (MLL) is a common target of chromosomal translocations in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).

MI-2
A3602-200	ApexBio	200 mg	EUR 1869.6
Description: MI-2 is a Menin-MLL inhibitor with IC50 value of 0.45 ?M [1]. Mixed-lineage leukemia (MLL) is a common target of chromosomal translocations in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).

MI-2
A3602-5	ApexBio	5 mg	EUR 254.4
Description: MI-2 is a Menin-MLL inhibitor with IC50 value of 0.45 ?M [1]. Mixed-lineage leukemia (MLL) is a common target of chromosomal translocations in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).

MI-2
A3602-5.1	ApexBio	10 mM (in 1mL DMSO)	EUR 498
Description: MI-2 is a Menin-MLL inhibitor with IC50 value of 0.45 ?M [1]. Mixed-lineage leukemia (MLL) is a common target of chromosomal translocations in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).

MI-2
A3602-50	ApexBio	50 mg	EUR 756
Description: MI-2 is a Menin-MLL inhibitor with IC50 value of 0.45 ?M [1]. Mixed-lineage leukemia (MLL) is a common target of chromosomal translocations in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).

MI-3
A3603-10	ApexBio	10 mg	EUR 480
Description: MI-3 is an inhibitor of Menin-Mixed linage leukemia (MML) protein interaction with IC50 value of 648 ± 25 nM [1].MLL protein is a histone methyltransferase that positively regulates gene transcription.

MI-3
A3603-100	ApexBio	100 mg	EUR 1863.6
Description: MI-3 is an inhibitor of Menin-Mixed linage leukemia (MML) protein interaction with IC50 value of 648 ± 25 nM [1].MLL protein is a histone methyltransferase that positively regulates gene transcription.

MI-3
A3603-5	ApexBio	5 mg	EUR 320.4
Description: MI-3 is an inhibitor of Menin-Mixed linage leukemia (MML) protein interaction with IC50 value of 648 ± 25 nM [1].MLL protein is a histone methyltransferase that positively regulates gene transcription.

MI-3
A3603-5.1	ApexBio	10 mM (in 1mL DMSO)	EUR 370.8
Description: MI-3 is an inhibitor of Menin-Mixed linage leukemia (MML) protein interaction with IC50 value of 648 ± 25 nM [1].MLL protein is a histone methyltransferase that positively regulates gene transcription.

MI-3
A3603-50	ApexBio	50 mg	EUR 1461.6
Description: MI-3 is an inhibitor of Menin-Mixed linage leukemia (MML) protein interaction with IC50 value of 648 ± 25 nM [1].MLL protein is a histone methyltransferase that positively regulates gene transcription.